Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Mol Cancer Ther. 2018 Nov 7;18(2):301–311. doi: 10.1158/1535-7163.MCT-18-0464

Figure 6.

Figure 6.

Biological schematic demonstrating that Uro A intercedes its antitumor effects by targeting PI3K/AKT/mTOR kinase pathways. Additionally, Uro A acts on macrophages, Tregs and MDSCs and thus inhibits tumor growth which enhances survival.